NCT05186025View on ClinicalTrials.gov

Tyrosine Allergoid Paediatric and Adult Study

Active, not recruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

November 6, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions
Allergic Rhinitis Due to PollenAllergic ConjunctivitisAllergic Asthma
Interventions
DRUG

MATA trees or MATA grass

Glutaraldehyde-modified and MCT® (MicroCrystalline Tyrosine)-adsorbed allergoids

Trial Locations (1)

Unknown

Universitätsklinikum Augsburg, Augsburg

Sponsors
All Listed Sponsors
collaborator

Bencard Allergie GmbH

OTHER

lead

Allergy Therapeutics

INDUSTRY